DOSSIER · 13F Holders · Q1 2026Healthcare · Pharmaceutical Preparations
DYN
DYNE THERAPEUTICS INC
252 institutions still hold DYNE THERAPEUTICS INC as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 26818M108·Pharmaceutical Preparations·252 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
252 institutions reported DYN in Q1 2026. T. Rowe Price Investment Management, Inc. leads at 18.2% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 13
232 more holders available. Log in →